Placeholder Banner

BIO Podcast 2023 Fall Season Launch

August 30, 2023
Media Contact
Theresa Brady
202.962.9235

New Season of I am BIO Podcast Covers Birds, Bees, and Bugs

Fall 2023 season explores biotech solutions for
wildlife conservation, bee health, drug-resistant bugs, and more

Washington – (Aug. 30, 2023) – Save the datethe Biotechnology Innovation Organization will launch the fall season of the I AM BIO podcast, on September 5th. The popular podcast began airing in 2020 and dives into conversations about cutting-edge innovations around healthcare and the role of biotech in shaping a sustainable future.

The season’s first episode explores scientists’ work on finding an alternative to using horseshoe crab blood to test for contaminants in drugs. Researchers have developed a synthetic alternative to the crab’s blood, and they believe that widespread adoption of the recombinant version will assist in conserving the crustacean, as well as the endangered birds that depend on them for food.

“Our podcast on the horseshoe crab is a fascinating story of how an animal that most of us have never even seen provides an essential ingredient for testing injectable pharmaceuticals. Yet it is not sustainable,” said Theresa Brady, Executive Producer of the I am BIO podcast. “A synthetic alternative provides us an exciting opportunity to significantly contribute to the conservation of the horseshoe crab and the red knot—an endangered shorebird that relies on the eggs of horseshoe crabs for survival.”

This, and other topics will round out a fall season full of insight into the world of biotechnology.

 Additional episodes will cover:

  • Biotech advances to save bees
  • Female scientists at the forefront of new technologies
  • How biotech start-ups survive the valley of death
  • The promise of synbio to make manufacturing more sustainable
  • Narrowly escaping death from an antimicrobial-resistant bug

Guests on the I AM BIO podcast are experts on the topics discussed and explain science in clear, engaging narratives.

In 2022, PR Daily named the I AM BIO podcast a finalist for its Social Media & Digital Awards in the podcast category. Listen now on BIO’s website, Apple Podcasts, Google Podcasts, or Spotify.

 

Discover More
Yesterday the Federal Trade Commission (FTC) announced the decision to settle its Amgen-Horizon merger challenge. The settlement will give the Commission the relief it needs to protect competition, while allowing rare disease patients to enjoy the…
The Biden Administration today unveiled the first 10 prescription drugs that will be subject to price controls under the Inflation Reduction Act (IRA). Rachel King, BIO interim President and CEO, made the following statement: The Medicare price…
BIO released the following statement from John Delacourt, BIO’s Deputy General Counsel, on BIO’s amicus brief opposing the Federal Trade Commission (FTC) lawsuit to block the acquisition of Horizon by Amgen: “The FTC’s current overreach in…